East Africa houses over half of the global HIV cases, and almost 5% of the population of Tanzania has HIV. Yet, only about half of the people with HIV consistently take anti-retroviral medication to treat it. Asili Research Alliance was born out of a calling to change these dire statistics. I speak with Jennifer Woltz of Asili about their innovative program working with local healers to supply a plant-based, locally sourced and produced medication that has known anti-HIV activity. Over 2,000 people have benefited from this treatment, either as a supplement to antiretroviral therapy (ART) or by itself when they are unable to obtain ART. The treatment is used to supplement ART or when ART is not an option (due to cost or scarcity). Their goal is to enable people living with HIV to regain their health in order to keep working and taking care of their families.
#HIV #Africa #TraditionalMedicine